Skyward Specialty Insurance SKWD
$64.43 +$0.89 (+1.40%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $64.20 -0.36%
Open$63.86
Prev close$63.54
Day range$63.86 – $65.95
Volume634.0K
Market cap$2.86B
P/E (TTM)15.0
Dividend yield–
SKWD Stock News
Headlines matching Skyward Specialty Insurance or the SKWD ticker, most recent first.
- Analysts Offer Insights on Financial Companies: Skyward Specialty Insurance Group, Inc. (SKWD) and Hiscox (OtherHCXLF)
- William Blair Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating
- Truist Financial Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Announces Target Price $75
- Analysts Offer Insights on Financial Companies: Pinnacle Financial Partners (PNFP), Affirm Holdings (AFRM) and Skyward Specialty Insurance Group, Inc. (SKWD)
- Truist Financial Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating
- Analysts Offer Insights on Financial Companies: Assurant (AIZ), Upstart Holdings (UPST) and Skyward Specialty Insurance Group, Inc. (SKWD)
- Barclays Sticks to Its Buy Rating for Skyward Specialty Insurance Group, Inc. (SKWD)
- Barclays Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Raises Target Price to $68 Positive
- Piper Sandler Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Maintains Target Price $72
- TD Cowen Maintains Skyward Specialty Insurance(SKWD.US) With Hold Rating, Raises Target Price to $65 Positive
- Analysts Offer Insights on Financial Companies: Skyward Specialty Insurance Group, Inc. (SKWD), American International Group (AIG) and GCM Grosvenor (GCMG)
- Analysts Conflicted on These Financial Names: Sixth Street Specialty Lending (TSLX), Enact Holdings (ACT) and Skyward Specialty Insurance Group, Inc. (SKWD)
- KBW Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Raises Target Price to $75 Positive
- KBW Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Raises Target Price to $72 Positive
- Piper Sandler Maintains Skyward Specialty Insurance(SKWD.US) With Buy Rating, Raises Target Price to $68 Positive
No comments yet — be the first to weigh in on SKWD.
Sign in to join the discussion.